-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes_hi_impact.pdf
March 01, 2012 - monotherapy and combination therapy (with oral hypoglycemic agents and insulin)
and to assess its cardiovascular … obesity and bariatric surgery in T2DM: effects on
physiopathology, metabolic control and global
cardiovascular
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-089-fullreport.pdf
January 30, 2017 - example, a measure
addressing childhood obesity may have implications for the subsequent development
of cardiovascular … in children and youth: A joint position statement by the Canadian Pediatric Society,
the Canadian Cardiovascular
-
meps.ahrq.gov/data_stats/nhc/hlthstat.pdf
September 30, 1997 - Disorder
Aphasia
Arteriosclerotic Heart Disease (ASHD)
Arthritis
Asthma
Cancer
Cardiac Dysrhythmia
Cardiovascular … (Bipolar Disease)
Cancer Missing Limb (e.g., Amputation)
Cardiac Dysrhythmia Multiple Sclerosis
Cardiovascular
-
www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/highlights/ps-project-highlights-medication-safety.pdf
April 30, 2025 - Significant predisposing
factors of ORAEs included mental health conditions, cardiovascular diseases … www.ahrq.gov/sites/default/files/2024-01/gurwitz-report.pdf
https://archive.ahrq.gov/chain/practice-tools/cardiovascular-risk … Stable
atherosclerotic cardiovascular disease and primary prevention were the prime targets for
APT
-
www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/reports/issue-briefs/nurse-role-dxsafety.pdf
September 02, 2022 - Nurses are key in preventing deadly
diagnostic errors in cardiovascular diseases.
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/chartbooks/personcentered/qdr2015-chartbook-personcenteredcare.pptx
September 01, 2016 - most effective prevention and treatment practices for the leading causes of mortality, starting with cardiovascular
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/surgery/modules/implementation/imp_ssibundle.pptx
December 01, 2017 - Development and pilot evaluation of a preoperative briefing protocol for cardiovascular surgery.
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2022.pdf
January 01, 2022 - The modifying effect of the serum-to-dialysate
potassium gradient on the cardiovascular safety of SSRIs
-
www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/reports/issue-briefs/dxsafety-reimagining-healthcare-teams.pdf
July 07, 2023 - How valuable is physical examination of the cardiovascular system?
-
hcup-us.ahrq.gov/reports/statbriefs/sb240-Co-occurring-Physical-Mental-Substance-Conditions-Hospital-Stays.pdf
February 01, 2018 - Depressive symptoms, health behaviors, and risk of
cardiovascular events in patients with coronary heart
-
integrationacademy.ahrq.gov/products/playbooks/behavioral-health-and-primary-care/planning-for-integration/define-your-vision
January 01, 2024 - and decreasing depressive symptoms in patients with multimorbidity involving depression and either cardiovascular
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ped-mindfulness-protocol-amendment.pdf
February 05, 2025 - Mindfulness and cardiovascular disease
risk: state of the evidence, plausible mechanisms, and theoretical
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ped-mindfulness-protocol-amended.pdf
September 25, 2024 - Mindfulness and cardiovascular disease
risk: state of the evidence, plausible mechanisms, and theoretical
-
hcup-us.ahrq.gov/reports/statbriefs/sb213-Safety-Net-Hospitals-2014.jsp
October 01, 2016 - likely to be for diabetes and skin infections, whereas stays at non-SNHs were more likely to be for cardiovascular
-
hcup-us.ahrq.gov/reports/statbriefs/sb213-Safety-Net-Hospitals-2014.pdf
January 01, 2014 - likely to be for diabetes and skin infections, whereas stays
at non-SNHs were more likely to be for cardiovascular
-
hcup-us.ahrq.gov/reports/statbriefs/sb198-Hospital-Stays-Medicare-Advantage-Versus-Traditional-Medicare.pdf
December 01, 2014 - MCC
208 Respiratory system diagnosis with ventilator support less than 96 hours
247 Percutaneous cardiovascular
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol3/Advances-Webster_76.pdf
July 18, 2008 - -
threatening, or fatal.18 In this group, the medications most involved with preventable ADEs were
cardiovascular
-
hcup-us.ahrq.gov/reports/methods/2012_01.pdf
January 01, 2012 - Examples include: health status, immunization, diabetes, tobacco use, HIV/AIDS,
arthritis, asthma, and cardiovascular
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017817-field-final-report-2012.pdf
January 01, 2012 - medication categories place patients at particularly high risk for adverse drug events,
including: cardiovascular
-
hcup-us.ahrq.gov/reports/methods/2008_06.pdf
January 01, 2008 - 320: KIDNEY & URINARY TRACT
INFECTIONS AGE >17 W CC
365,118 0.9 366,156 0.9
527: PERCUTANEOUS
CARDIOVASCULAR